Contents
Autumn 2024
Analytics
Peter O’Toole, president of the Royal Microscopical Society (RMS), comments on the winners of the RMS Science Section Award 2025.
Discovery and Development
Considering the importance and cost associated with oligonucleotide-based therapeutics, how can innovative computing imaging techniques be used to aid in the process, while also creating an audit trail and increasing the data dervied from these experiments?
Manufacturing
18 SPOT LIGHT
In the fast-paced world of pharmaceutical manufacturing, efficiency and precision are non-negotiable. For manufacturers dealing with difficult-to-encapsulate powders and formulations, the Natoli NCF-45 Capsule Filling Machine emerges as a game-changer.
There are usually two parameters important to pharma manufacturers: time and money. Is everything still on schedule? And are they still on budget? They need non-stop insight.
Focusing on regulation within pharmaceutical manufacturing can help re-centre a company’s priorities, while ensuring compliance.
Following good manufacturing practices (GMP) is crucial for stability testing. The analytical data generated from stability studies is a pivotal part of a regulatory dossier submission to substantiate the shelf life claimed for the drug product or drug substance and further support that shelf-life post-approval.
Digital
34 SPOT LIGHT
IPT speaks to Michael Ruch at TaBlitz about the use of AI in tablet design, why it’s effective and how it will develop in the future.
Large language models can be useful in the pharmaceutical industry in order to streamline digital capabilities. However, steps must be taken in order to mitigate the phenomenon of AI hallucinations.
Pharma laboratories should be looking to innovative digital techniques such as data, AI and the cloud to aid drug discovery and research.
AI, especially GenAI, is becoming increasingly popular in the pharma and life sciences industries. How can companies use large language models – and more specifically, retrieval augmented generation architectures – to ensure AI-generated results are accurate?
Features
The 17th European Microscopy Congress (EMC2024) took place at the Bella Center in Copenhagen, Denmark, from 26-30 August 2024 with an attendance of 2,500 registrants from at least 51 countries, who had the opportunity to hear from researchers at various career levels from both academia and industry.
Join us at CPHI Milan 2024, the premier global event for pharmaceutical professionals, from 8-10 October at Fiera Milano, Milan, Italy. Celebrating 35 years of excellence, this event promises unparalleled opportunities for networking, innovation and professional growth. With over 62,000 attendees and 2,500 exhibitors, you’ll experience insightful seminars, cutting-edge exhibitions and new awards such as ‘Woman of the Year’ and ‘Future Leader’.
Regulars
The Autumn weather is brisk and blustery, but it won’t rain on pharma manufacturing’s parade!
IPT highlights some of the most recent exciting advancements in pharmaceutical manufacturing.
A collation of the top Pharma events for the end of 2024.
Index of Advertisers
EXECUTIVE DIRECTOR
PMGroup Worldwide Ltd
Karl Equi
GROUP MANAGING EDITOR
PMGroup Worldwide Ltd
Iona Everson
DEPUTY EDITORS
Charlie Blackie-Kelly
DEPUTY EDITORS
James Spargo
Natalia Elliot
SALES
Louise Wilson-English
DESIGN
Peter May
FRONT COVER
sergey kolesnikov
Shutterstock
DIGITAL EDITION
IPT Online
www.iptonline.com
CONTACT US
Tel: +44 (0)20 7724 3456
Fax: +44 (0)20 7403 7747
PRINTING
Pureprint Group
www.pureprint.com
SUBSCRIPTIONS AND DATA
Curwood CMS Ltd
Unit 9 Barns & Stables,
Timworth Green,
IP31 1HS
c-cms.com
Tel: 01580 883841
Email: enquiries@c-cms.com
www.iptonline.com
Innovations in Pharmaceutical Technology (ISSN: 1471-7204, USPS No: 025082) is published four times a year – March, June, September, and December – by Samedan Ltd.
The opinions and views expressed by the authors in this book are not necessarily those of the Editor the Publisher and, while every care has been taken in the preparation of the book, the Editor and the Publisher are not responsible for such opinions and views or for
any inaccuracies in the articles.
The Publisher is not responsible for any images supplied by contributors. While every care is taken with artwork supplied, the Publisher cannot be held responsible for any loss or damage incurred.
The entire content of this publication is protected by copyright. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form, by any means – electronic,
mechanical, photocopying, or otherwise – without the prior permission of the Publisher.
© 2024 Samedan Ltd
Pharmaceutical Publishers